— Know what they know.
Not Investment Advice
Also trades as: BSLN.SW (SIX) · $vol 3M · 0QNA.L (LSE) · $vol 1M

BPMUF OTC

Basilea Pharmaceutica AG
1W: -1.5% 1M: -1.5% 3M: +26.5% YTD: +20.6% 1Y: +12.6% 3Y: +86.0% 5Y: +41.2%
$76.25
-1.15 (-1.49%)
 
Weekly Expected Move ±0.7%
$75 $76 $76 $77 $77
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 66 · $943.7M mcap · 11M float · 0.0003% daily turnover · Short 100% of daily vol

📊 Key Metrics

TTM
$483M
Revenue
+49.5% YoY
$125M
Net Income
+124.8% YoY
$133M
Free Cash Flow
+263.6% YoY
87.0%
Gross Margin
26.5%
Op. Margin
23.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE140.1%
ROA51.5%
ROIC185.7%

Valuation

P/E15.7
P/B5.1
EV/EBITDA0.0

Leverage

Debt/Equity0.51
Current Ratio6.60
Interest Cov.150.7x

Quality Scores

Piotroski F9/9
Altman Z—
Beneish M-2.12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms